Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+०.०८%
१,०८६.६७
+०.८६
+०.०८%
—१,०८५.८११,०८३.२३१,०८८.१०१,०७४.०८——
SIXC
Communications
SIXC
Communications
SIXC
+०.१६%
६०८.६८
+०.९९
+०.१६%
—६०७.६९६०७.६९६०९.८९६०४.०२——
SIXE
Energy
SIXE
Energy
SIXE
+०.३१%
१,१९६.१२
+३.७४
+०.३१%
—१,१९२.३८१,२००.०६१,२०६.८५१,१८६.६५——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.१५%
१,७५३.७५
-२.६४
-०.१५%
—१,७५६.३९१,७५३.५३१,७५४.७२१,७३३.५२——
SIXM
Financials
SIXM
Financials
SIXM
-०.२६%
६३१.६५
-१.६२
-०.२६%
—६३३.२७६३१.३६६३३.९०६२८.७५——
SIXR
Staples
SIXR
Staples
SIXR
-०.०४%
८५२.०४
-०.३८
-०.०४%
—८५२.४२८५३.२५८५६.२०८५१.०६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+०.०१%
२१८.८१
+०.०२०
+०.०१%
—२१८.७९२१८.७९२१९.१७२१७.२६——
SIXT
Technology
SIXT
Technology
SIXT
+१.३१%
३,७६०.२९
+४८.६०
+१.३१%
—३,७११.६९३,७१९.२९३,७६०.५५३,६९९.८८——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.८६%
९०३.२१
-७.८४
-०.८६%
—९११.०५९०९.९९९१३.३४९०२.५६——
SIXV
Health care
SIXV
Health care
SIXV
+१.१८%
१,५१८.३५
+१७.६९
+१.१८%
—१,५००.६६१,५०४.१६१,५२६.६३१,५०४.१६——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.११%
२,४५२.१४
-२.८२
-०.११%
—२,४५४.९६२,४५०.६३२,४५६.५०२,४३५.७२——
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०२३
-४.१७%
(-०.००१०) 1D
मे २८, १६:१०:१७ GMT+१०  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
A$ ०.०२
High
A$ ०.०२
Low
A$ ०.०२
Mkt. cap
७.५५ करोड
Avg. vol.
२.७६ करोड
Volume
८०.६२ लाख
52-wk high
A$ ०.४०
52-wk low
A$ ०.०२
EPS
-A$ ०.०५
Shares outstanding
२.७३ अरब
No. of employees
११
News stories
From sources across the web
MarketBeat
MarketBeat
·
८ मिनेट पहिले
AeroVironment (NASDAQ:AVAV) Shares Gap Up - Time to Buy?
24/7 Wall St.
24/7 Wall St.
·
२९ मिनेट पहिले
Investor Turns $70K to $4M Using This S&P 500 Bull ETF
Reuters
Reuters
·
१ घण्टा पहिले
Wall St muted as investors asses inflation data, Mideast peace prospects
AL.com
AL.com
·
१ घण्टा पहिले
Global firm with Alabama headquarters debuts on Nasdaq
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees११
Founded१९८४
Headquarters-
Sector-
Websitebotanixpharma.com
Last report
२०२६ जनवरी २७
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
८२.५३ लाख / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
२७.०६ लाख
२७.०६ लाख
८२.५३ लाख
८२.५३ लाख
Cost of goods sold
१२.८१ लाख
१२.८१ लाख
२९.८० लाख
२९.८० लाख
Cost of revenue
१२.८१ लाख
१२.८१ लाख
२९.८० लाख
२९.८० लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.१४ करोड
२.१४ करोड
१.८३ करोड
१.८३ करोड
Operating expense
२.६९ करोड
२.६९ करोड
२.२१ करोड
२.२१ करोड
Total operating expenses
२.८२ करोड
२.८२ करोड
२.५१ करोड
२.५१ करोड
Operating income
-२.५५ करोड
-२.५५ करोड
-१.६८ करोड
-१.६८ करोड
Other non operating income
-
-
६.८३ लाख
६.८३ लाख
EBT including unusual items
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
EBT excluding unusual items
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
Net profit margin
-१,०२५.७३%
-१,०२५.७३%
-२०१.११%
-२०१.११%
Earnings per share
-
-
-
-
Interest and investment income
३.४७ लाख
३.४७ लाख
३.५३ लाख
३.५३ लाख
Interest expense
-२६.६६ लाख
-२६.६६ लाख
-८.०२ लाख
-८.०२ लाख
Net interest expenses
-२३.१९ लाख
-२३.१९ लाख
-४.५० लाख
-४.५० लाख
Depreciation and amortization charges
५.७३ लाख
५.७३ लाख
५.९३ लाख
५.९३ लाख
EBITDA
-२.४९ करोड
-२.४९ करोड
-१.६२ करोड
-१.६२ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer